메뉴 건너뛰기




Volumn 60, Issue 2, 2012, Pages 339-346

Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: Insights from fosidiAL

Author keywords

blood pressure; cardiovascular; chronic; clinical trial; hemodialysis; prognosis; renal insufficiency

Indexed keywords

FOSINOPRIL; PLACEBO;

EID: 84864286539     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.190397     Document Type: Article
Times cited : (90)

References (29)
  • 1
    • 0041878535 scopus 로고    scopus 로고
    • Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States
    • DOI 10.1016/S0002-9343(03)00366-8
    • Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the united states. Am J Med. 2003;115:291-297. (Pubitemid 37088191)
    • (2003) American Journal of Medicine , vol.115 , Issue.4 , pp. 291-297
    • Agarwal, R.1    Nissenson, A.R.2    Batlle, D.3    Coyne, D.W.4    Trout, J.R.5    Warnock, D.G.6
  • 2
    • 0036405062 scopus 로고    scopus 로고
    • Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study
    • DOI 10.1046/j.1523-1755.2002.00636.x
    • Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS waves 3 and 4 study. Kidney Int. 2002;62:1784-1790. (Pubitemid 35286287)
    • (2002) Kidney International , vol.62 , Issue.5 , pp. 1784-1790
    • Foley, R.N.1    Herzog, C.A.2    Collins, A.J.3
  • 4
    • 48049113051 scopus 로고    scopus 로고
    • Cardiac problems in the dialysis patient: Beyond coronary disease
    • Remppis A, Ritz E. Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial. 2008;21:319-325.
    • (2008) Semin Dial , vol.21 , pp. 319-325
    • Remppis, A.1    Ritz, E.2
  • 5
    • 67649889627 scopus 로고    scopus 로고
    • Cardiovascular protection with antihypertensive drugs in dialysis patients: Systematic review and meta-Analysis
    • Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-Analysis. Hypertension. 2009;53:860-866.
    • (2009) Hypertension , vol.53 , pp. 860-866
    • Agarwal, R.1    Sinha, A.D.2
  • 6
  • 7
    • 23844465424 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients
    • K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1-S153.
    • (2005) Am J Kidney Dis , vol.45
  • 8
    • 0037337398 scopus 로고    scopus 로고
    • Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
    • DOI 10.1046/j.1523-1755.2003.00803.x
    • Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793-808. (Pubitemid 36315558)
    • (2003) Kidney International , vol.63 , Issue.3 , pp. 793-808
    • Kalantar-Zadeh, K.1    Block, G.2    Humphreys, M.H.3    Kopple, J.D.4
  • 9
    • 77749245884 scopus 로고    scopus 로고
    • Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
    • Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938-948.
    • (2010) Lancet , vol.375 , pp. 938-948
    • Rothwell, P.M.1
  • 10
    • 77749251836 scopus 로고    scopus 로고
    • Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
    • Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
    • (2010) Lancet , vol.375 , pp. 895-905
    • Rothwell, P.M.1    Howard, S.C.2    Dolan, E.3    O'brien, E.4    Dobson, J.E.5    Dahlof, B.6    Sever, P.S.7    Poulter, N.R.8
  • 11
    • 79551479820 scopus 로고    scopus 로고
    • The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994
    • Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160-166.
    • (2011) Hypertension , vol.57 , pp. 160-166
    • Muntner, P.1    Shimbo, D.2    Tonelli, M.3    Reynolds, K.4    Arnett, D.K.5    Oparil, S.6
  • 13
    • 33748949733 scopus 로고    scopus 로고
    • Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies
    • DOI 10.1038/sj.ki.5001657, PII 5001657
    • Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 2006;70:1318-1324. (Pubitemid 44435184)
    • (2006) Kidney International , vol.70 , Issue.7 , pp. 1318-1324
    • Zannad, F.1    Kessler, M.2    Lehert, P.3    Grunfeld, J.P.4    Thuilliez, C.5    Leizorovicz, A.6    Lechat, P.7
  • 14
    • 0036434418 scopus 로고    scopus 로고
    • FOSIDIAL: A randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics
    • DOI 10.1046/j.1472-8206.2002.00127.x
    • Zannad F, Kessler M, Grunfeld JP, Thuilliez C. Fosidial: A randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients-study design and patients' baseline characteristics. Fundam Clin Pharmacol. 2002;16:353-360. (Pubitemid 35356945)
    • (2002) Fundamental and Clinical Pharmacology , vol.16 , Issue.5 , pp. 353-360
    • Zannad, F.1    Kessler, M.2    Grunfeld, J.P.3    Thuilliez, C.4
  • 17
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2- 4
    • Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387. (Pubitemid 26072233)
    • (1996) Statistics in Medicine , vol.15 , Issue.4 , pp. 361-387
    • Harrell Jr., F.E.1    Lee, K.L.2    Mark, D.B.3
  • 19
    • 36749072988 scopus 로고    scopus 로고
    • Predictors of cardiovascular events in patients with end-stage renal disease: An analysis from the Fosinopril in Dialysis study
    • DOI 10.1093/ndt/gfm417
    • Kessler M, Zannad F, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the fosinopril in dialysis study. Nephrol Dial Transplant. 2007;22:3573-3579. (Pubitemid 350212486)
    • (2007) Nephrology Dialysis Transplantation , vol.22 , Issue.12 , pp. 3573-3579
    • Kessler, M.1    Zannad, F.2    Lehert, P.3    Grunfeld, J.P.4    Thuilliez, C.5    Leizorovicz, A.6    Lechat, P.7
  • 21
    • 79551487009 scopus 로고    scopus 로고
    • Prognostic value of long-term blood pressure variability: The evidence is growing
    • Mancia G. Prognostic value of long-term blood pressure variability: The evidence is growing. Hypertension. 2011;57:141-143.
    • (2011) Hypertension , vol.57 , pp. 141-143
    • Mancia, G.1
  • 22
    • 77149163349 scopus 로고    scopus 로고
    • Blood pressure and mortality among hemodialysis patients
    • Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55:762-768.
    • (2010) Hypertension , vol.55 , pp. 762-768
    • Agarwal, R.1
  • 23
    • 0032772770 scopus 로고    scopus 로고
    • Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease
    • DOI 10.1093/ndt/14.8.1976
    • Tozawa M, Iseki K, Yoshi S, Fukiyama K. Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transplant. 1999;14:1976-1981. (Pubitemid 29358897)
    • (1999) Nephrology Dialysis Transplantation , vol.14 , Issue.8 , pp. 1976-1981
    • Tozawa, M.1    Iseki, K.2    Yoshi, S.3    Fukiyama, K.4
  • 24
    • 79951697850 scopus 로고    scopus 로고
    • The role of blood pressure variability in the development of nephropathy in type 1 diabetes
    • Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care. 2010;33:2442-2447.
    • (2010) Diabetes Care , vol.33 , pp. 2442-2447
    • Kilpatrick, E.S.1    Rigby, A.S.2    Atkin, S.L.3
  • 25
    • 77749282912 scopus 로고    scopus 로고
    • Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-Analysis
    • Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-Analysis. Lancet. 2010;375:906-915.
    • (2010) Lancet , vol.375 , pp. 906-915
    • Webb, A.J.1    Fischer, U.2    Mehta, Z.3    Rothwell, P.M.4
  • 26
    • 68549140186 scopus 로고    scopus 로고
    • Volume-Associated ambulatory blood pressure patterns in hemodialysis patients
    • Agarwal R. Volume-Associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension. 2009;54:241-247.
    • (2009) Hypertension , vol.54 , pp. 241-247
    • Agarwal, R.1
  • 28
    • 66849138375 scopus 로고    scopus 로고
    • Arterial hypertension induced by erythropoietin and erythropoiesis- stimulating agents (ESA)
    • Krapf R, Hulter HN. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol. 2009; 4:470-480.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 470-480
    • Krapf, R.1    Hulter, H.N.2
  • 29
    • 5644236567 scopus 로고    scopus 로고
    • Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects
    • Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis. 2004;44:16-21.
    • (2004) Am J Kidney Dis , vol.44 , pp. 16-21
    • Goodkin, D.A.1    Young, E.W.2    Kurokawa, K.3    Prutz, K.G.4    Levin, N.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.